GlassScriptPhysician profile
Nina Prata
NPI 1093157422
$4,863.99
in general payments reported to CMS, 2019-2025
29 companies · $799 in 2025
The $799 reported for 2025 was more than what 84% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $243 · 2022: $1,273 · 2023: $1,710 · 2024: $839 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,231 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,231.40 |
| Education | $116.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,252.05 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $854.89 | 2021-2025 | Ofev |
| Genzyme Corporation | $409.21 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $406.64 | 2022-2025 | |
| Axsome Therapeutics, INC. | $274.90 | 2022-2025 | Sunosi |
| Regeneron Healthcare Solutions, INC. | $245.01 | 2021-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $162.26 | 2021-2025 | Fasenra, Tezspire, Airsupra |
| Grifols USA, LLC | $143.26 | 2022-2025 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $136.59 | 2022-2024 | Wakix |
| Amgen INC. | $123.33 | 2022-2024 | Tezspire |
| Sanofi-Aventis U.S. LLC | $117.47 | 2022-2024 | |
| Baxter Healthcare | $108.04 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Insmed, INC. | $79.28 | 2022-2023 | Arikayce |
| Mylan Specialty L.P. | $77.52 | 2021-2023 | Yupelri |
| Ani Pharmaceuticals, INC. | $60.38 | 2023 | Purified Cortrophin Gel |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $49.75 | 2021-2025 | Acthar |
| Abbvie INC. | $47.37 | 2023-2025 | |
| United Therapeutics Corporation | $45.97 | 2022-2023 | Tyvaso |
| Merck Sharp & Dohme LLC | $44.33 | 2023-2025 | Winrevair |
| Covis Pharma Gmbh | $41.38 | 2022-2023 | |
| Teva Pharmaceuticals USA, INC. | $31.47 | 2022 | |
| Pulmonx Corporation | $25.96 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| 3b Medical, INC. | $25.70 | 2025 | Luna |
| Actelion Pharmaceuticals US, INC. | $25.65 | 2023 | Uptravi |
| Alexion Pharmaceuticals, INC. | $20.52 | 2023 | Ultomiris |
| Viatris Specialty LLC | $17.72 | 2025 | Yupelri |
| Electromed, INC. | $14.11 | 2023 | Smartvest |
| Pfizer INC. | $13.38 | 2022 | |
| Inogen, INC. | $9.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nina Prata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.